People on the Move: J.D. Mowery, CDMO Chief, Bora Pharmaceuticals
Bora Pharmaceuticals strengthens its U.S. presence with the acquisition of Emergent BioSolutions’ Baltimore-Camden facility, appointing J.D. Mowery as Division President to drive growth and innovation in the global CDMO sector.
October 14, 2024
| BioBuzz’s mission is simple: to be more connected. Our regionally-focused storytelling, programs, events and experiences connect, amplify and create impact across the life science workforce in growing biohubs. Submit your People On The Move (free and ongoing) to showcase your company’s growth by promoting your new hires and recent promotions. |
Bora Pharmaceuticals, a leading global CDMO with over 50 years of experience, recently expanded its U.S. presence by acquiring Emergent BioSolutions’ Baltimore-Camden facility for $30 million. This acquisition secures 350 jobs and strengthens Baltimore’s biomanufacturing sector, while also enhancing Bora’s ability to serve its global pharmaceutical partners. Known for its commitment to quality and innovation, Bora now supplies medical products to over 100 countries, and the addition of this facility further boosts its capacity to deliver cutting-edge healthcare solutions.
In addition to acquiring the facility, Bora Pharmaceuticals has appointed J.D. Mowery as Division President. With nearly 25 years of experience in the CDMO and biopharmaceutical industries, Mowery is well-equipped to provide strategic direction, enhance operational efficiency, and drive the growth of Bora’s CDMO services across its world-class facilities in North America and Taiwan. His leadership will ensure that Bora continues to deliver high-quality, innovative solutions to clients around the globe.
Additional duties of Mowery will include expanding the company’s market presence, optimizing operational efficiency, and addressing the evolving needs of the pharmaceutical industry. With an extensive background in operations, manufacturing, and business development, Mowery is expected to significantly help position Bora as a leader in the CDMO sector.
Bobby Sheng, Group Chairman and CEO of Bora shared, “I am thrilled to welcome J.D., who brings nearly 25 years of experience in the CDMO and biopharmaceutical industries. I look forward to working with him to meet the needs of our customers and of this rapidly growing organization.”
About J.D. Mowery
J.D. Mowery brings nearly 25 years of experience in the CDMO and biopharmaceutical sectors. Before joining Bora Pharmaceuticals, he served as President and CEO of KBI Biopharma, a JSR Life Sciences company, where he successfully led global CDMO operations. Besides being a backbone to KBI biopharma, J.D. Mowery has also held other positions of power at prestigious companies such as Genentech, Treadwell Therapeutics, Juno Therapeutics, and Celgene. He has also held executive positions with leading CDMO organizations like Lonza and AGC Biologics. Working for many prestigious firms has made him acquire expertise in operations, manufacturing, tech transfer, facility construction, and business development. He has also managed to master investor relations across North America, Europe, and Asia. Regarding educational background, Mowery holds a bachelor’s degree from George Fox University. He also has an MBA from Marylhurst University, making him well-equipped to drive Bora’s strategic growth in the pharmaceutical industry.
About Bora Pharmaceuticals
Bora Pharmaceuticals Co., Ltd. is a leading global contract development and manufacturing organization (CDMO) that helps develop, manufacture, and sell branded, generic, and over-the-counter healthcare products. It was founded in 2007 and has since built a strong foundation on a 50-year history rooted in Hoan Pharmaceuticals. It is now committed to providing quality and innovative pharmaceutical products. With an international presence and network, the company supplies high-quality medical drugs to over 100 countries, including the U.S., Canada, Japan, the EU, Asia, the Middle East, and South and Central America. It specializes in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, and semi-solid pharmaceutical products. With a dedicated team of professionals and state-of-the-art facilities across North America and Asia, Bora is a trusted partner for leading pharmaceutical companies worldwide.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
